Agilent splits its bioanalytical business

September 14, 2009

LCGC Europe eNews

LCGC Europe eNews-09-11-2009, Volume 0, Issue 0

Agilent Technologies has announced that it will be separating its Life Science and Chemical Analysis Group (LSCA) into two businesses - the Chemical Analysis Group and the Life Sciences Group.

Agilent Technologies has announced that it will be separating its Life Science and Chemical Analysis Group (LSCA) into two businesses - the Chemical Analysis Group and the Life Sciences Group. According to the company, the change in its structure reflects the opportunities it sees in the two areas and supports the company’s long-term aim of developing into a leading bioanalytical company.

In a statement to the press, Bill Sullivan, the company’s president and CEO, said, "The decision to create two separate businesses within bioanalytical measurement reflects the need to serve distinct sets of customers."

The company reports that effective immediately, the current vice president and general manager of the Chemical Analysis Solutions Unit within the LSCA, Mike McMullen, has been promoted to senior vice president of Agilent and president of the new Chemical Analysis Group. His counterpart in the LSCA’s Life Sciences Solutions Unit, Nick Roelofs, will also be promoted to SVP of the company and has become the president of the new Life Sciences Group.

As of 1 November 2009 the company will be comprised of three separate business groups: Electronic Measurement, Chemical Analysis and Life Sciences.

For more information on the company visit www.agilent.com

Related Content:

News